RSA gambar
RSA SKATEPARK AND STORE
Breaking News
Loading...
Recent Post
FG TROCHES MEIJI
FG TROCHES MEIJI
COMPOSITION
Each troche contains :
Fradiomycin 2,5
mg (potency)
Gramicidin 1,0
mg (potency)
PHARMACOLOGY
Fradiomycin and Gramicidin are antibiotic that acted
bactericidal, active to staphylococci and prevention of postoperative (oral
surgery) infections.
DOSAGE
in general, admiister 1 or 2 troches to adult and 1 troches
to children 4 to 5 times a day. The troches should be dissolved in the oral or
buccal cavity or under the tongue.
PRECAUTION
1)
Before use of this product,
as a rule, confirm bacterial sensitivity to prevent development of resisteant
bacteria. The period of administration should restricted to sithin the minimum
requirement.
2)
Do not administer the
troches for more than one week.
3)
Discontinue treatment upon
the onset of hypersensitivity reaction.
4)
Use in elderly.
The product should be administered carefully
to elderly patients, since arderse reaction such as avitaminosis are likely to
occur.
ADVERSE REACTION
Black hairy tongue, oral muosal redness, glossitis may infrequently
occur. Rarely, symptoms of vitamin K deficiency, such as protrombinemia and
bleeding tendency and of vitamin B deficiency, suc as glossitis, stomatitis,
anorexia and neruritis, may occur. These symptoms are likely to occur in poorly
nourished, aged or emaciated patients.
CONTRAINDICATION
Do not administer the troches to patients with a history of
hypersensitivity reaction to any component of the product and patiens with
history of hypersensitivity reactions to aminoglycosides such as streptomycin,
kanamycin, gentanicin and fradiomycin or bacitracin.
STORAGE
Store at a cool and dry place (150 – 250C)
PRESENTATION
Box of 12 strips @ 10 troches
DRAMAMINE dimenhydrinate bp
DRAMAMINE
DIMENHYDRINATE BP 50 mg
COMPOSITION
Each tablet contains :
Dimenhydrinate BP 50
mg
INDICATION
Prevention and relief of motion sickness and treatment of
vertigo, nausea or vomiting associated with : electroshock therapy, anaesthesia
and surgery, labyrinthine disturbances, radiation sickness and post fenestraton
syndrome.
WARNINGS
Caution should be used when DRAMAMINE is given in conjuction
with certain antibiotics which mah cause ototoxicity, since DRAMAMINE is
capable of masking ototoxic symptoms and irreversible state may be reached
Although clinical studies in pregnant women have not
indicated that DRAMAMINE increases the risk of foetal abnormalities, it, like
any drug, should be used durngi pregnancy only it benefits outweigh the risk.
As small amounts of DRAMAMINE are excreted in breast milk, benefits of therapu
must be weighed against potential adverse reactions in nursing infants.
ADRVERSE REACTIONS
Drowsiness may be experienced by some patients, especially
those on high dosage, although this effect frequently is not undersirable in
some conditions for which the drug is used. However atiens should be cautioned
against operating automobiles or dangerous machinery while taking
DRAMAMINEbecause of possible drug-associated drowsiness.
DOSAGE AND ADMINISTRATION
Tablets :
DRAMAMINE is available as
a 50 mg tablet
Adults : The adults
therapeutic and prophylactic dose is 50 to 100 mg three or four times daily.
Children :
Ages 6-8 years :
12,5 mg to 25 mg (1/4 to1/2 tablet)
Two or three times daily
Ages 8-12 years :
25 to 50 mg (1/2 to one tablet)
Two or there times daily
Ages 12 years and older : 50 mg (one tablet)
Two or three tines daily
For prevention of motion sickness the firs dose should be
given 30 menute before departure
STORAGE
Store below 300C
Keep out of reach of children
PRESENTATION
Box @ 100 tablets (10 strip @ 10 tablet)
PT TAISHO PHARMACEUTICAL
Neuralgin RX (methampirone thiamine pyridoxine cyanocobalamin, trimethylxanthine)
NEURALGIN RX
Methampirone, Thiamine HCl, Pyridoxine HCl, Cyanocobalamin,
Trimethylxanthine.
COMPOSITION
Each film coaterd caplet contains :
Methampyrone 500
mg
Thiamine HCl 50 mg
Pyridoxine HCl 10 mg
Cyanocobalamin 10 mg
Trimethylxanthine 50 mg
PHARMACOLOGY
Methampyrone is a potent nonnarcotic analgesic – antipyretic
drug. It is a pyrazolon derivative with therapeutic efficacy equivalent to that
of acetosal, the standard drug for the
nonnarcotic analgesic – antipyretic class. It cause less gastric irritation
that acetosal and does not produce the acid – base or metabolic effect of
salicylate.
Hewever, it has been implicated for many heares to cause a
high incident of agranulocytosis. An epidemiologic study of international scale
involving about 30 million people had been especially designed to study this
matter.
The study was completed just recently and the results showed
that methampurone , in fact, accounted for only a very low incidence of
agranulocytosis.
Trimethylxanthine is commonly added to an analgesic as an
analgesic adjuvant. In a dose of 50 mg or more, trimethylxanthine has been
shown to enhance the analgesic efficacy of acetosal adan acetaminophen; in this
case methampyrone should not be an exception.
Thiamine HCl, pyridoxine HCl and cyanocobalamin are
neurotropic vitamins; deficiency of any of these vitamins may cause some form
of neurologic disturbance.
INDICATIONS
Relief of mild to severe pain, such as headache especially
tension headache, myalgia, arthralgia, neuralgia, lumbago, tootache, menstrual
pain, pain from cancer, biliary and renal colic, postpartum pain, postoperative
pain.
CONTRAINDICATION
1.
Hypersensitivity to
methampurone and other nonsteroidal anti inflammatory drugs.
2.
Concomitant administration
with chlorpromazine (may result in serious hypothermia)
PRECAUTIONS
1.
Use with caution in - peptic ulcer (active/history)
- hemostatic defect (avoid) or
anticoagulant therapy
- severe liver disease
- pregnancy (not recommended)
especially late pregnancy.
- nursing mother (not
recommended)
- infants
- history of blood dyscasia.
2.
Discontinue the drug if the
following develops :
·
Fever, some throat or
stomatitis (may indicated agranulocytosis, hematologic evaluation should be
performed)
·
Evidence of peptic
ulceration or gastrointestinal bleeding.
ADVERSE REACTIONS
The most frequent are gastrointestinal symtoms, such as
nausea, vomiting, epigastric discomfort etc.
NERUALGIN RX may also cause hypersensitivity reactions, e.g.
skin rashes and pruritus. Side effect occuring rarely are gastrointestinal
bleeding and ulceration, leukopenia and agranulcytosis.
DOSAGE
Adult :
1-2 caplets 3 to 4 times daily
Children : ½
-1 caplet 3 to 4 times daily
If gastrointestinal discomfort occurs, administer NEURALGIN
RX with or after meals
STORAGE
Sore below 300C
PRESENTATION
Box of 10 strips x 10 film coated caplets.
Reg.No. DKL8511603809A1
PT KALBE FARMA
OTOLIN Ear Drop
OTOLIN
Chloramphenicol,
Polymyxin
B. Sulphate,
Benzocaine,
Nipagin
Ear
drop
COMPOSITION
Each
mL contains :
Chloramphenicol 5 %
Polymyxin
B. Sulphate, 10.000 IU
Benzocaine
1 %
Nipagin 1 %
PHARMACOLOGY
Chloramphenicol
is an antibiotic, which has a wide range of antimicrobial actinity including
both Gram-positive and Gram-negative microorganisms. Topically and in ear drops
Chloramphenicol is of value and is often effective even when such
microorganisms as P. vulgaris and Ps. Aeruginosa which are resistant to many
antibacterial agents are present.
Polymyxin
B. sulphate is an antibiotic of choice in the treatment of incections caused by
susceptible strains of Gram-negative bacteria including many starins of Ps.
Aeruginosa, which are the mst destructive pathogens found in topical and ear
infections.
This
combination ensures eradication of the pathogenic microorganisms, and reduces
the risk of developing resesteance to one of antibiotics. Benzocaine help
relieve the pain, while nipagin in concretration of 1 % gives a strong
antiseptic effect.
INDICATIONS
OTOLIN is indicated in the treatment of acute and
chronic otitis externa caused bay microorganisms susceptible to Chloramphenicol
and Polymyxin B. sulphate.
CONTRAINDICATION
OTOLIN
is contraindicated in persons sensitive to any of ists components.
PRECAUTIONS
Prolonged
use may result in overgrowth of non-suciptible microorganisms. If sensitivity
or irritation occurs, medication should be discontinued promptly.
DOSAGE
3
-4 drops in effected ear 3 or 4 times daily.
STORAGE BELOW 300C
PROTECT FROM LIGHT
PRESENTATION
Bottle
of 10 mL
Reg.
No. DKL7211639748A1
PT
KALBE FARMA
KSR potassium Chloride
KSR
Potassium Chloride
Potassium supplement
COMPOSITION
Each film-coated SR tablet contains Potassium Chloride 600
mg
MODE OF ACTION
KSR is a film-coated preparation of potassium chloride
formulated for slow release.
Each tablet contains 600mg of potassium chloride which is
equivalent to 8 mili-equivalent each of Potassium [K+] and Chloride
[Cl-]. The show and sustained release over a period of 6 hours
precludes high concentration of potassium chloride against a localized area of
the gut wall which might irritate or damage the mucosa. The sustained relase
providers conditions of maximum gastric tolerance and effective absorpstion for
the treatment of all types of potassium deficiency, whether hypochloraemic
alkalosis. KSR does not alter normal kidney function; can be used in all age
groups; replaces the essential chloride anion and potassium and so prevents
hypochloraemic alkalosis. During KSR administration, laboratory monitoring of
serum electrolyte level should be done periodically.
INDICATIONS
For treatment and specific prevention of hypokalemia.
DOSAGE and ADMINISTRATION
An average dose is 1 or 2 tablet two or three times daily,
each tablet swallowed whlle with little water, preferably during meals. Where
KSR is administerd routinely with an average daily maintenance dose of an oral
diuretic agent, 1-2 tablet daily may be sufficient.
WARNINGS
If a patien under treatment with KSR develops severe
vomiting, severe abdominal pains or flatulence, or gastoristesinalhaemorrhage,
the preparation should be withdranwn at once. To prevent the risk of
hyperkalemia, potassium supplements should not be administered with potassium
sparing diuretic agent such spironolactone, triamterene or amiloride. In case of
metabolic acidosis, hypokalemia should not be treated with potassium chloride
but with a potassium salt containing an alkalosing anion [e.g potassium
bicarbonate].
PRECAUTIONS
In patien with impaired renal function , special care should
be exercised when prescribing potassium salt because of the risk of
hypokalaemia. The serum electrolytes should be monitored in these patiens and
also in patiens with congestive heart failure, especially if under treatment
with digitalis, in whom hypokalemia should be avoided.
ADVERSE RACTIONS
Oral potassium preparatons can provoke gastrointestinal
disturbance (e.g. nausea vomiting, abdominal pain, diarrhea). In rare cases,
KSR may also cause these side-effect. In this evevnt, reduction in dosage or
withdrawal of drug may be necessary.
CONTRAINDICATION
Advanced ernal failure, untreated Addison;s disease, acute
dehydration, hyperkalemia, in the presence of obstruction in the digestivetract
(e.g. resulting from compression of the oesophagus due to dilation of the left
atrium or from stenosis of the gut). The administration of KSR in such a situation could be conceivably give
rise to ulceration or perforaton.
STORAGE
Store in a dry place below 250C
PRESENTATIONS
Bottle of 100 film coated SR tablets
Box of 10 x 10 film coated SR tablet in strip
PT MERCK
Urispas 200 Flavoxate hydrochloride
URISPAS 200
Flavoxate Hydrochloride 200mg
COMPOSITION
Each film coated tablet contains
flavoxate hydrochloride 200mg
MECHANISME OF ACTIONS
Flavoxate hydrochloride is a
flavone derivative.
The basic action of Urispas is
the relaxation of smooth muscle fibres of the urinary tract
INDICATIONS
Urispas is indicated for the
symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency
and incontinence as many occur in cystitis, prostatitis, urethritis,
urethrocystitis, and urethrotrigonitis.
DOSAGE AND ADMINSTRATION
Adult and children over 12 years
of age : 200 mg 3 – 4 times a day.
With improvement of symptoms,
the dose may be reduced.
PRECAUTIONS
Urispas should be given
cautiously to patiensts with suspected glaucoma. The drug should only be used
during pregnancy if the anticipated benefits outweigh any risk. Not recommended
for infants and children under 12 years of age since safety and efficacy
studies in this age group are not completed.
In the event of drowsiness or
blurred vision, the patients should not operate a motor wehicle or any
machinery, and refrain from participating in activites requiring alertness. If
overdosage occur, maximus 4 hours after overdosage, evacuation of the stomach
should be performed. If overdosage is extreme, or there is a delay in removing
the drug from the stomach, administration of a parasympathomimetic drug should
be considered. Administration in nursing mother only if clearly needed.
ADVERSE REACTION
Nausea, vomiting, dry mouth,
nervousness vertigo, headache, drowsiness, blurred vision, increased ocular
tension, disturbance in eye accommodation, mental confusion, dysuria,
tachycardia, palpitation, hyperpurexia, eosinophilia, leukopenia, urticarial and
other dermatoses.
CONTRAINDICATION
URISPAS is contraindication in
pationts who have any of the following conditions; pyloric or duodenal
obstrucion, obstructive intestinal lesions or ileus, achalasia,
gastrointestinal hemorrhage and obstructive uropathies of the lower urinary
tract.
STORAGE
Keep in a cool and dry place
PRESENTATION
Box, 3 blister @10 film coated
tablet
RECODARTI S.p.A.
ASPAR-K supplement potassium aspartate
ASPAR-K
Potassium aspartate preparation
COMPOSITION AND DESCRIPTION
Generic name : Potassium L-aspartate
Product’s name
|
Content of Potassium
L-aspartate
|
Description of the product
|
ASPAR-K
|
300 mg per tablet (K : 1,8 mEq)
|
White film-coated tablet
|
ACTIONS
PHARMACOLOGICAL ACTIONS :
A potassium ion, one of the main electrolytes in the cell,
has actions such as to induce the membrane potential, to maintain the osmotic
pressure and to control the acid-base equilibrium.
When the red blood cell is employed as a sample to examine
the transport of potassium into the tissues, potassium L-aspartate proves a
beter intake by the tissues than potassium chloride.
ABSORPTION AND EXCRETION :
When the amount of Potassium L-aspartate equivalent to 20
mEq/kg/day of potassium was administered for 32 days to rats fed on food
lacking porassium for 24 days, the eman amount of potassium excreted in the
feces was 26.1 µEq/head/day.
Namely, the absorption rate of potassium from the intestines was not less than
99,5% because the mean administration amount of potassium was 5,497 µEq/head/day.
TOXICOLOGY AND TERATOLOGY
1.
Acute toxicity :
The LD50 of Potassium L-aspartate in male
rats is not less than 10000 mg/kg, 4,061 mg/kg, 1500 mg/kg and 667 mg/kg by
oral, subcutaneous, intraperitoneal and intravenous routes, respectively.
2.
Chronic toxicity :
After administration fo 4g/kg
3.
Teratology
Fetal toxicity in mice and rats was evaluated
in accordance with the Measurements for Safety of Drug by the Japanese Ministry
of Health & Welfare, and no significant difference was observed between
administration and control group.
INDICATIONS
Potassium supplement in the following diseases and symptoms
accompanied with the imbalance of electrolytes :
Cardiac diseases
Liver diseases
Periodic tetraplegia due to hypokalemia,
Hypokalemia due to prolonged administration of antihypertensi
diuretics, adrenal cortical steroid, digitalis and insulin
Other disorder of potassium metabolism (pre- and
post-operative course, diarrhea, vomiting)
ADMINISTRATION AND DOSAGE
Take 1 to 3 tablets three times daily
The dose may be increased according to the secerity of
symptoms and condition of patients.
CAUTION ON USE
1.
CONTRAINDICATION :
1)
Patiens with Addison;s
disease untreated
2)
Patient with hyperkalemia
3)
Patient with
hypersensitivity to the drug components
2.
USES WITH CAUTION
On administration to those patiens with
advanced hypo functioned or damaged kidneys, including those suspected of such
disorders, whose serum and urnary electrolytes should be carefully examined.
3.
ADVERSE REACTION :
a.
Digestive system : anorexia and gastric disturbances have
been encountered.
b.
Heart : precordial heavy feeling
has been noted.
4.
IT IS ADVISABLE NOT TO
ADMINISTER THE DRUG to premature infants, newborns and infats, because the
drug is reported to cause at 250 mg/kg or more as asparticc acid some
histopathological change in the nucleous arciformis of the hypothalamus in mice
and rats at the age of 3 week or below.
5.
INTERACTION :
Since the following drug may cause
hyperkalemia, concurent use with the should be exercised with much care
·
Antialdosterone preparation
·
triamterene
CAUTION AND HANDLING
As the tablet are hygroscopic the container and tablet must
be kept in a cool and dry place
STORAGE
Store in a tigh and light-resistent container at below 300C
PRESENTATION
Box of 10 aluminium strips of 10 tablets
MITSUBISHI TANABE PHARMA CORPORATION
Privacy Policy
Privacy Policy for Lyrics-An Eye
If you require any more information or have any questions about our privacy policy, please feel free to contact us by email at http://lyrics-aneye.blogspot.com/2015/09/contact-us.html.At lyrics-aneye.blogspot.co.id we consider the privacy of our visitors to be extremely important. This privacy policy document describes in detail the types of personal information is collected and recorded by lyrics-aneye.blogspot.co.id and how we use it.
Log Files
Like many other Web sites, lyrics-aneye.blogspot.co.id makes use of log files. These files merely logs visitors to the site - usually a standard procedure for hosting companies and a part of hosting services's analytics. The information inside the log files includes internet protocol (IP) addresses, browser type, Internet Service Provider (ISP), date/time stamp, referring/exit pages, and possibly the number of clicks. This information is used to analyze trends, administer the site, track user's movement around the site, and gather demographic information. IP addresses, and other such information are not linked to any information that is personally identifiable.
Cookies and Web Beacons
lyrics-aneye.blogspot.co.id uses cookies to store information about visitors' preferences, to record user-specific information on which pages the site visitor accesses or visits, and to personalize or customize our web page content based upon visitors' browser type or other information that the visitor sends via their browser.
DoubleClick DART Cookie
→ Google, as a third party vendor, uses cookies to serve ads on lyrics-aneye.blogspot.co.id.
→ Google's use of the DART cookie enables it to serve ads to our site's visitors based upon their visit to lyrics-aneye.blogspot.co.id and other sites on the Internet.
→ Users may opt out of the use of the DART cookie by visiting the Google ad and content network privacy policy at the following URL - http://www.google.com/privacy_ads.html
Our Advertising Partners
Some of our advertising partners may use cookies and web beacons on our site. Our advertising partners include .......
- Commission Junction
- Amazon
- Widget Bucks
- Adbrite
- Clickbank
- Linkshare
- Yahoo! Publisher Network
- Azoogle
- Chitika
- Kontera
- TradeDoubler
- Other
You may consult this listing to find the privacy policy for each of the advertising partners of lyrics-aneye.blogspot.co.id.
These third-party ad servers or ad networks use technology in their respective advertisements and links that appear on lyrics-aneye.blogspot.co.id and which are sent directly to your browser. They automatically receive your IP address when this occurs. Other technologies (such as cookies, JavaScript, or Web Beacons) may also be used by our site's third-party ad networks to measure the effectiveness of their advertising campaigns and/or to personalize the advertising content that you see on the site.
lyrics-aneye.blogspot.co.id has no access to or control over these cookies that are used by third-party advertisers.
Third Party Privacy Policies
You should consult the respective privacy policies of these third-party ad servers for more detailed information on their practices as well as for instructions about how to opt-out of certain practices. lyrics-aneye.blogspot.co.id's privacy policy does not apply to, and we cannot control the activities of, such other advertisers or web sites. You may find a comprehensive listing of these privacy policies and their links here: Privacy Policy Links.
If you wish to disable cookies, you may do so through your individual browser options. More detailed information about cookie management with specific web browsers can be found at the browsers' respective websites. What Are Cookies?
Children's Information
We believe it is important to provide added protection for children online. We encourage parents and guardians to spend time online with their children to observe, participate in and/or monitor and guide their online activity. lyrics-aneye.blogspot.co.id does not knowingly collect any personally identifiable information from children under the age of 13. If a parent or guardian believes that lyrics-aneye.blogspot.co.id has in its database the personally-identifiable information of a child under the age of 13, please contact us immediately (using the contact in the first paragraph) and we will use our best efforts to promptly remove such information from our records.
Online Privacy Policy Only
This privacy policy applies only to our online activities and is valid for visitors to our website and regarding information shared and/or collected there. This policy does not apply to any information collected offline or via channels other than this website.
Consent
By using our website, you hereby consent to our privacy policy and agree to its terms.
Update
This Privacy Policy was last updated on: Saturday, September 12th, 2015.
Should we update, amend or make any changes to our privacy policy, those changes will be posted here.
Subscribe to:
Posts
(
Atom
)
Copyright © 2013
Lyrics-An Eye
All Right Reserved